A sensitive and specific double antibody radioimmunoassay has been developed capable of measuring LH-RH in extracted human plasma. Thyrotropin releasing hormone, lysine vasopressin and most of LH-RH analogues did not appear to affect the assay.
Since the amino acid sequence of luteinizing hormone releasing hormone (LH-RH) was proposed by Matsuo et al. (1971) , synthetic LH-RH has been widely used to study hypothalamic-pituitary-gonad interact ions. In such studies, LH-RH stimulation test was recognized as a useful tool for differentiating the site of lesion of abnormal gonadotropin secretion (Saito et al., 1973) , but, needless to say, measurement of LH-RH per se is more essential for understanding the hypothalamic control of gonadotropin release. Although LH-RH activity has been measured in biological fluid (McCann et al., -1960; Mlacara et al ., 1972; Seiler and Reichlin, 1973) and hypothalamic extracts (Kobayashi et al., 1961; Seki et al., 1972) by bioassay, the complexities inherent in bioassay techniques have not made measurement of LH-RH a feasible procedure for most investigations. It seems that a radioimmunoassay of releasing hormone should be most desirable for reasons of sensitivity and simplicity, but to date only few reports of LH-RH measurement by radioimmunoassay (Nett et al., 1973; Keye et al., 1973; Saito et al., 1974; Arimura et al., 1974; Jeffcoate et al., 1974; Musa et al., 1975) have appeared.
This report deals with a successful production of an antiserum against LH-RH and with the development of a radioimmuno- Preparation o, f anti-LH-RH Synthetic LH-RH was rendered immunogenic by coupling it to bovine serum albumin (BSA) with bis-diazotized benzidine (BDB) according to the method of Bassiri and Utiger (1972) . The LH-RH-BDB-BSA conjugate was diluted with 0.15 M NaCl so that the protein concentration was 1 mg/ml. Equal volumes of diluted LH-RH-BDB-BSA conjugate and complete Freund's adjuvant were mixed and 1.0 ml of this mixture injected in the foot pads of each of three white rabbits. The immunization was repeated at 2-4 weeks' intervals.
The animals were bled by central ear artery 1-2 weeks after each immunization to check antibody formation. Preparation of LH-RH free human plasma Activated charcoal (Norit A) was added to a pool of normal human plasma in a concentration of 50 mg per ml, mixed with a Vortex mixer for 10 minutes, and the charcoal was removed by the combination of centrifugation and filtration. To test the adequacy of the charcoal procedure for the removal of LH-RH from plasma, 0.5 pc 1311-LH-RH was added to 5 ml plasma. After treated with charcoal, one-tenth ml of filtered plasma was used for counting the radioactivity and it was compared with the radioactivity of the plasma before charcoal treatment. More than 99% of radioactivity was absorbed by charcoal. 
Results
Iodination and binding of labeled LH RH with antiserum Figure 1 shows a typical pattern of the distribution of radioactivity in Sephadex G-25 fractions of iodination products resulting from chloramine T method. The three main peaks were observed. The first peak contained free 1311. The third peak showed a binding of about 60% to the antiserum (final dilution 1: 30,000) by immunoreactive studies and was found most useful for radioimmunoassay, while the second peak less reactive.
Specificity of and -LH-RH serum
Addition of increasing quantities of unlabeled LH-RH to reaction mixtures containing 1311-LH-RH and anti-LH-RH serum resulted in a progessive decrease of 1311-LH-RH precipitated.
As little as 3 pg LH-RH has been detected ( Fig. 2) , if a 10% reduction in binding to B0/T was taken. The specificity of the anti-LH-RH serum was The results of these experiments are shown in Figure 3 and Table 1 . Thyrotropin releasing hormone, lysine vasopressin and BSA did not show any crossreactivity with anti-LH-RH serum in the dose range used. As shown in Fig. 3 , rat hypothalamic extract and [G1n8]-LH-RH produced inhibition curves parallel to that obtained with LH-RH in the region where the binding percentage was ranged from 20% to 90%.
The antiserum was observed to be highly specific for that portion of LH-RH molecule distal to the site of conjugation to protein (Table 1) .
Recovery of LH-RH from plasma
Addition of 12.5-100 pg of LH-RH to 2 ml of charcoal-absorbed plasma were quantitatively recovered after extraction as shown in Table 2 Plasma levels of LH-RH in normal subjects Plasma LH-RH concentrations in normal subjects are presented in Figure 5 . In all of children (4 males and 3 females) plasma LH-RH levels were less than 3 pg/ml and in adults (14 males, 16 females) less than 20 pg/ml. However, the plasma LH-RH levels shows a tendency to increase in aged males over 60 yr and postmenopausal women. within 1 to 3 min. Figure 7 shows the disappearance curves of each case. The excretion of immunoreactive LH-RH into urine was 0.2-0.4% of the injected dose in the first hour.
Discussion
The results described in this communication clearly show that immunization with LH-RH-BDB-BSA conjugate emulsified with complete Freund's adjuvant induced a formation of specific anti-LH-RH serum in rabbits. The specificity of the antiserum was examined by determining the ability of various LH-RH analogues (Table 1) ,. hypothalamic extract and some peptides (Figure 3 ) to inhibit 131I-LH-RH binding to antibody. It was shown that extent of cross-reaction observed was minimal in almost all of LH-RH analogues, although some of the analogues modified at the position near to N-terminus showed high crossreactivity to antiserum.
However, these compounds do seem to exist none or less in blood. Other hypothalamic and pituitary hormones as far as tested did not interfere with the binding of LH-RH to the antiserum. These results indicate LH-RH radioimmunoassay using this antiserum may be quite specific for LH-RH determination in biological materials.
The iodination of LH-RH was successfully achieved by chloramine T method.
The immunoreactive 131I-LH-RH was eluted in the third peak, later from Sephadex G-25 column than its molecular weight would indicate. This is presumably due to absorption (Jeffcoate et al., 1974) . The first peak represented free 131I and the second peak damaged fraction.
Extraction of LH-RH from plasma samples before radioimmunoassay confers two major advantages.
First, the removal of potential interfering substances such as plasma proteins or other unknown factors is achieved. Enzymatic degradation must be prevented by this procedure. The second advantage is a possibility of concentrating plasma LH-RH. Thus, the assay detection limit was improved when applied to plasma.
Enzymatic degradation appears to be a knotty problem associated with radioimmuoassay of TRH but not of LH-RH at least within 2 hours after sampling when preserved in the cold. However, the inactivation of immunoreactivity proceeds so constantly (Figure 4) , that the plasma LH-RH is recommended to be assayed as soon as possible, or extracted from the plasma prior to determination. Keye et al. (1973) (1974) plasma LH-RH concentration of 5 women were 1.8 pg/ml or less in early follicular stage and increased in all cases reaching as high as 17 pg/ml in midcycle. At mid-luteal stage LH-RH returned to low level in all but one women. We also found that plasma LH-RH concentration was significantly higher in midcycle stage than in follicular and luteal stages. Since LH secretion reaches its peak level at midcycle, these findings may indicate preovulatory surge of LH is related to the increased secretion of LH-RH. It has been well known that plasma LH and FSH levels increase in postmenopausal women and some aged males. Our preliminaly measurements show that plasma LH-RH levels elevate in many of aged males over 60 years and postmenopausal women. This corresponds to the literature (Malacara et al., 1972) in which bioassay was used. This also indicates that gonadotropin secretion is closely related to LH-RH secretion.
However, Seiler and Reichlin (1974) recently reported a fluctuation of LH-RH secretion like LH and pointed out that physiological and pathological studies should take this into account and that frequent and continuous sampling techniques may have to be used. Further studies are required to clarify the aspects of LH-RH secretion by increasing the sensitivity of LH-RH assay which makes it possible to measure in all normal cases in small amount of test materials. Then, hypothalamic control of gonadotropin secretion will be elucidated in detail.
The disappearance of LH-RH in human blood is rapid 4112=4-6 min) in our cases as reported by several authors (Keye et al., 1973; Jeffcoate et al., 1973) . It corresponds to kinetic studies using isotope-labeled LH-RH (Miyachi et al., 1973; Redding et al., 1973) . If endogenous LH-RH is cleared at a similar rate, evaluation of its secretory pattern in periferal plasma will require frequent sampling. In contrast to the kinetic studies using labeled LH-RH, the urinary excretion of immunoreactive LH-RH was only 0.2-0.4% of the injected dose. Similar values were reported by Jeffcoate et al. (1974) . The difference may be interpreted as that majority of isotope excreted into urine is derived from metabolites of LH-RH (Redding et al., 1973) and/or inorganic iodine (Tachizawa et al., 1974) . Jeffcoate et al. (1974) 
